AILIS Breast Cancer

AILIS is an innovative diagnostics company based in Warsaw, Poland, focused on revolutionizing breast cancer screening. Its flagship AILIS Breast Health Monitoring System uses a proprietary, non-contact DPI technology combined with AI to provide a painless, radiation-free exam that is particularly effective for women with dense breast tissue, a population poorly served by traditional mammography. The company, founded in 2019, is currently in the clinical evaluation stage, positioning itself to address a significant global gap in accessible and comfortable early detection. Its business model centers on the development and future commercialization of a medical device and associated software platform.

Dynamic Parametric Imaging (DPI) hardware combined with proprietary artificial intelligence algorithms for breast tissue analysis and risk prediction. The integrated platform includes telemedicine and mobile application capabilities.

Competes against standard mammography, supplemental screening methods like ultrasound and MRI, and a growing field of AI software for mammogram analysis. Differentiates through a non-contact, non-radiation hardware approach and a focus on the dense breast population. Must also compete for adoption against established, low-cost screening infrastructure.